Clinical Trial Update: PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia [Phase 2]

View source ↗

Summary

Phase II clinical trial update for PA21 in hemodialysis patients with hyperphosphatemia has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Requiring Hemodialysis

Drugs mentioned

• PA21 (PA21)

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Chronic Kidney Disease Requiring Hemodialysis | Phase 2 | Status: COMPLETED | Results posted: 2018-08-23